GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Syngene International Ltd (NSE:SYNGENE) » Definitions » Days Sales Outstanding

Syngene International (NSE:SYNGENE) Days Sales Outstanding : 47.21 (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Syngene International Days Sales Outstanding?

Syngene International's average Accounts Receivable for the three months ended in Mar. 2025 was ₹5,267 Mil. Syngene International's Revenue for the three months ended in Mar. 2025 was ₹10,180 Mil. Hence, Syngene International's Days Sales Outstanding for the three months ended in Mar. 2025 was 47.21.

The historical rank and industry rank for Syngene International's Days Sales Outstanding or its related term are showing as below:

NSE:SYNGENE' s Days Sales Outstanding Range Over the Past 10 Years
Min: 48.51   Med: 62.79   Max: 76.34
Current: 48.51

During the past 13 years, Syngene International's highest Days Sales Outstanding was 76.34. The lowest was 48.51. And the median was 62.79.

NSE:SYNGENE's Days Sales Outstanding is ranked better than
71.63% of 208 companies
in the Medical Diagnostics & Research industry
Industry Median: 63.455 vs NSE:SYNGENE: 48.51

Syngene International's Days Sales Outstanding increased from Mar. 2024 (43.95) to Mar. 2025 (47.21).


Syngene International Days Sales Outstanding Historical Data

The historical data trend for Syngene International's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syngene International Days Sales Outstanding Chart

Syngene International Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 76.34 71.60 61.44 50.79 48.52

Syngene International Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.95 51.03 49.56 46.79 47.21

Competitive Comparison of Syngene International's Days Sales Outstanding

For the Diagnostics & Research subindustry, Syngene International's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syngene International's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Syngene International's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Syngene International's Days Sales Outstanding falls into.


;
;

Syngene International Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Syngene International's Days Sales Outstanding for the fiscal year that ended in Mar. 2025 is calculated as

Days Sales Outstanding (A: Mar. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2024 ) + Accounts Receivable (A: Mar. 2025 )) / count ) / Revenue (A: Mar. 2025 )*Days in Period
=( (4416 + 5267) / 2 ) / 36424*365
=4841.5 / 36424*365
=48.52

Syngene International's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding (Q: Mar. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Mar. 2025 )) / count ) / Revenue (A: Mar. 2025 )*Days in Period
=( (0 + 5267) / 1 ) / 10180*365 / 4
=5267 / 10180*365 / 4
=47.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syngene International  (NSE:SYNGENE) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Syngene International Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Syngene International's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Syngene International Business Description

Traded in Other Exchanges
Address
Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The Company is engaged in a single operating segment of providing contract research and manufacturing services. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the US. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.

Syngene International Headlines

No Headlines